CLASS ACTION UPDATE for IGT, FRSH and EIGR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Loading...
Loading...

NEW YORK, NY / ACCESSWIRE / November 11, 2022 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

IGT Shareholders Click Here: https://www.zlk.com/pslra-1/igt-lawsuit-submission-form?prid=33602&wire=1
FRSH Shareholders Click Here: https://www.zlk.com/pslra-1/freshworks-class-action-loss-submission-form?prid=33602&wire=1
EIGR Shareholders Click Here: https://www.zlk.com/pslra-1/eiger-biopharmaceuticals-class-action-lawsuit-submission-form?prid=33602&wire=1

* ADDITIONAL INFORMATION BELOW *

International Game Technology PLC IGT

IGT Lawsuit on behalf of: investors who purchased March 16, 2018 - August 29, 2022
Lead Plaintiff Deadline : December 13, 2022
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/igt-lawsuit-submission-form?prid=33602&wire=1

According to the filed complaint, during the class period, International Game Technology PLC made materially false and/or misleading statements and/or failed to disclose that: (i) IGT overstated its compliance with gaming and lottery laws and applicable regulations; (ii) IGT and/or one or more of its current and/or former subsidiaries engaged in illegal gambling operations; (iii) the foregoing conduct subjected the Company and/or its current and/or former subsidiaries to a heightened risk of litigation and significant related costs; (iv) the Company downplayed the full scope and severity of its financial exposure to, and/or liabilities in connection with, the lawsuit filed against IGT's subsidiary in April of 2018; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Freshworks Inc. FRSH

This lawsuit is on behalf of persons and entities that purchased Freshworks common stock pursuant to and/or traceable to documents issued in connection with the Company's initial public offering.
Lead Plaintiff Deadline : January 3, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/freshworks-class-action-loss-submission-form?prid=33602&wire=1

According to the complaint, the documents used to effectuate Freshworks' initial public offering were false and misleading and omitted to state that, at the time of the initial public offering, the Company's business had encountered obstacles. As a result of these obstacles, Freshworks' net dollar retention rate was plateauing, and its revenue growth rate and billings were decelerating.

Eiger BioPharmaceuticals, Inc. EIGR

Loading...
Loading...

EIGR Lawsuit on behalf of: investors who purchased March 10, 2021 - October 4, 2022
Lead Plaintiff Deadline : January 9, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/eiger-biopharmaceuticals-class-action-lawsuit-submission-form?prid=33602&wire=1

According to the filed complaint, during the class period, Eiger BioPharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) defendants overstated Eiger's clinical and regulatory drug development expertise; (ii) defendants failed to properly assess, and/or ignored issues with, the design of the TOGETHER study and its ability to support the Emergency Use Authorization ("EUA") for the Company's product candidate, peginterferon lambda ; (iii) there were issues with the conduct of the TOGETHER study and/or the TOGETHER study was not properly designed for the peginterferon lambda EUA in the current context of the pandemic; (iv) as a result, the U.S. Food and Drug Administration was unlikely to approve the submission of a peginterferon lambda EUA; (v) as a result of all the foregoing, peginterferon lambda's regulatory and commercial prospects for the treatment of COVID-19 were overstated; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE : Levi & Korsinsky, LLP



View source version on accesswire.com:

https://www.accesswire.com/725221/CLASS-ACTION-UPDATE-for-IGT-FRSH-and-EIGR-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

Loading...
Loading...
Posted In: Press ReleasesBusiness & Professional Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...